sym-trinitrobenzene has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaoka, T; Yamashita, U | 1 |
| Hamuro, J; Isawa, M; Kondoh, N; Yoshimoto, R | 1 |
2 other study(ies) available for sym-trinitrobenzene and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.
Topics: Animals; Cell Separation; Cytotoxicity, Immunologic; Haptens; Immune Sera; Major Histocompatibility Complex; Mammary Neoplasms, Experimental; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Plasmacytoma; Rabbits; Spleen; T-Lymphocytes; Trinitrobenzenes | 1979 |
Plant lectin, ATF1011, on the tumor cell surface augments tumor-specific immunity through activation of T cells specific for the lectin.
Topics: Animals; Antibody-Producing Cells; Cell Line; Cytotoxicity, Immunologic; Female; Killer Cells, Natural; Lectins; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Plant Lectins; T-Lymphocytes; Trinitrobenzenes | 1987 |